Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol.

cebranopadol (TRN-228) - Tris Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42420592

H Eric Xu; Shi-Yi Shen; Wen Hu; Xin-Yi Huang; Ya-Li Lai; Yue Wang

Jul 9, 2026